Linked Data API

Show Search Form

Search Results

1665086
unstar this property registered interest false more like this
star this property date less than 2023-10-16more like thismore than 2023-10-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rare Diseases: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many single technology appraisals for medicines for rare diseases conducted by the National Institute for Health and Care Excellence resulted in (a) a positive recommendation, (b) an optimised recommendation, (c) a recommendation for managed access, (d) a negative recommendation and (e) termination in each financial year since 2018-19. remove filter
star this property tabling member constituency Bolton West more like this
star this property tabling member printed
Chris Green remove filter
star this property uin 202779 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-10-20more like thismore than 2023-10-20
star this property answer text <p>The following table shows a breakdown of technologies with designated orphan status appraised through the National Institute for Health and Care Excellence resulted single technology appraisal process by financial year from 2018/19:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td><td><p>Total</p></td></tr><tr><td><p>Recommended</p></td><td><p>2</p></td><td><p>1</p></td><td><p>6</p></td><td><p>11</p></td><td><p>5</p></td><td><p>25</p></td></tr><tr><td><p>Recommended (Cancer Drugs Fund)</p></td><td><p>2</p></td><td><p>2</p></td><td><p>4</p></td><td><p>0</p></td><td><p>0</p></td><td><p>8</p></td></tr><tr><td><p>Optimised</p></td><td><p>3</p></td><td><p>9</p></td><td><p>3</p></td><td><p>3</p></td><td><p>8</p></td><td><p>26</p></td></tr><tr><td><p>Optimised (Cancer Drugs Fund)</p></td><td><p>1</p></td><td><p>1</p></td><td><p>0</p></td><td><p>1</p></td><td><p>0</p></td><td><p>3</p></td></tr><tr><td><p>Research Only</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>Not Recommended</p></td><td><p>2</p></td><td><p>0</p></td><td><p>0</p></td><td><p>1</p></td><td><p>2</p></td><td><p>5</p></td></tr><tr><td><p>Total</p></td><td><p>10</p></td><td><p>13</p></td><td><p>13</p></td><td><p>16</p></td><td><p>15</p></td><td><p>67</p></td></tr><tr><td><p>Terminated</p></td><td><p>1</p></td><td><p>5</p></td><td><p>5</p></td><td><p>10</p></td><td><p>2</p></td><td><p>23</p></td></tr></tbody></table><p> </p><p>Medicines with an orphan designation are for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition that is rare, namely affecting not more than five in 10,000 people in Great Britain, or where the medicine is unlikely to generate sufficient profit to justify research and development costs.</p>
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-10-20T11:24:13.29Zmore like thismore than 2023-10-20T11:24:13.29Z
unstar this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4398
unstar this property label Biography information for Chris Green more like this